CBD and Placebo Both Outperformed No Treatment in a Student Stress Trial

Improvement compared with no treatment did not demonstrate a CBD-specific benefit in a student stress trial summarized by a review. Both CBD and placebo improved some outcomes, while their direct comparison did not show a significant difference.

Three groups answered two questions

The review describes Winkler and colleagues’ randomized study involving 180 university students with elevated stress and risk of depression. Participants received CBD oil, placebo oil or no treatment over 30 days.

Stress, depressive symptoms and somatization improved in both oil groups relative to the untreated group. The review reports no significant CBD–placebo difference. Anxiety, sleep quality and general well-being also did not show significant improvements across groups.

The comparator changes the inference

Comparing CBD with no treatment includes the effects of receiving an intervention, expectations and other aspects of participation. Comparing CBD with a matching placebo more directly addresses whether the active preparation adds benefit under those conditions.

A decline from a person’s baseline is therefore insufficient to establish a drug effect. The untreated comparison is informative, but it cannot replace the placebo comparison when the claim concerns CBD’s specific efficacy.

Apply the result to its population

These were stressed students, not a representative sample of patients with every anxiety or depressive disorder. The tested regimen and duration also limit generalization.

The review supports a narrow conclusion: the trial did not demonstrate added benefit over placebo on the reported outcomes. It does not prove that every CBD regimen is ineffective, nor does it establish a treatment recommendation.

Related: Why outcomes must remain specific to the tested domain.

Research cited

Șolea R; Șerban E; Călugăr-Solea SF; et al.. Pharmaceuticals (2026). Cannabis and Cannabinoids: The Medical Potential of Cannabidiol in Mental and Neurological Disorders.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Randomized CBD Burnout Study Was Open-Label and Did Not Test Antiviral Efficacy

Random assignment did not make a CBD burnout study blinded, and improvement in pandemic-related distress did not demonstrate treatment of viral infection. A supplied review’s account of the BONSAI study requires both distinctions. The clinical target was burnout and emotional distress The review describes a prospective, randomized, open-label study of…

Spread the love

Read Article: A Randomized CBD Burnout Study Was Open-Label and Did Not Test Antiviral Efficacy

Smoking-Related Lung Observations Did Not Isolate THC as the Cause

Lung findings in people who smoked cannabis cannot automatically be attributed to THC alone. A historical chapter recognized that smoke contains multiple plant constituents and combustion products, making component-specific claims more difficult than simply identifying cannabis use. The chapter assembled different kinds of evidence Nahas discussed clinical reports of respiratory…

Spread the love

Read Article: Smoking-Related Lung Observations Did Not Isolate THC as the Cause

Historical Developmental-Toxicity Reports Used Different Cannabis Preparations

Historical developmental-toxicity findings varied across cannabis extracts, purified cannabinoids, animal species and exposure procedures. A chapter describing those experiments does not support treating every result as a controlled comparison of the same substance. The chapter described conflicting animal observations Nahas summarized developmental findings after cannabis resin or concentrated extracts and…

Spread the love

Read Article: Historical Developmental-Toxicity Reports Used Different Cannabis Preparations

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us